Health Care & Life Sciences » Biotechnology | Addex Therapeutics Ltd.

Addex Therapeutics Ltd.

Addex Therapeutics Ltd.
Stock Exchange Frankfurt Stock Exchange
EPS
-
Market Cap
-
Shares Outstanding
28.56 M
Public Float
-
Addex Therapeutics Ltd.
Stock Exchange SIX Swiss Exchange
EPS
CHF0.05
Market Cap
CHF46.5 M
Shares Outstanding
32.85 M
Public Float
19.3 M

Profile

Address
12, Chemin des Aulx
Geneva Geneve (Geneva) 1228
Switzerland
Employees -
Website http://www.addextherapeutics.com
Updated 07/08/2019
Addex Therapeutics Ltd. is a biopharmaceutical company, which engages in the development of drugs for human health. It develops novel, orally available, and small molecule allosteric modulators for neurological disorders. The company was founded by Vincent Mutel, Timothy Dyer, and Mark Epping-Jordan in 2002 and is headquartered in Geneva, Switzerland.

Financials

View All

Vincent M. Lawton
Chairman
Timothy Dyer
Chief Executive Officer & Director